Not yet recruiting psychedelic research trials
Data as of 31 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.
Not yet recruiting is a registry status. The study is registered but has not opened to participants yet. Status is reported by the study team and can change.
Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.
At a glance
- 67 registered studies are counted on this page.
Which substances
Counts per substance hub. Ketamine is limited to studies classified as psychiatric research, and records about disease-modifying therapy that match the abbreviation DMT are removed.
By phase
| Phase | Studies | Share |
|---|---|---|
| Early Phase 1 | 3 | 4% |
| Phase 1 | 18 | 27% |
| Phase 2 | 31 | 46% |
| Phase 3 | 3 | 4% |
| Phase 4 | 2 | 3% |
| Not applicable | 6 | 9% |
| Not reported | 4 | 6% |
Countries
Country is taken from the study's linked research site. 13 of 67 records have no country on file. The top 10 countries are shown.
| Country | Studies | Share |
|---|---|---|
| United States | 33 | 49% |
| Canada | 7 | 10% |
| Switzerland | 3 | 4% |
| China | 2 | 3% |
| Australia | 1 | 1% |
| Brazil | 1 | 1% |
| Spain | 1 | 1% |
| Finland | 1 | 1% |
| France | 1 | 1% |
| Israel | 1 | 1% |
Registry-listed start years
| Start year | Studies |
|---|---|
| 2024 and later | 67 |
Study design
- 63 interventional and 4 observational studies.
- Median planned or actual enrolment is 48 participants (range 3 to 220, across 67 records that report it).
Topics named in study titles
A keyword match on registered titles, so one study can appear under more than one topic and a study can be missed. It describes what titles mention, nothing more.
| Topic | Studies |
|---|---|
| Depression and mood | 19 |
| Other substance use | 8 |
| Trauma and PTSD | 7 |
| Cancer and end of life | 5 |
| Pain and headache | 4 |
| Suicidal thoughts | 4 |
| Alcohol use | 2 |
| Anxiety | 1 |
Latest registry-listed start dates
The 25 studies with the latest start dates, newest first. Dates may be estimated, including future dates; a listed date does not confirm that a study started. The order is not a ranking. Each ID links to its own ClinicalTrials.gov record.
| Registry ID | Title as registered | Status | Phase | Country | Registry dates |
|---|---|---|---|---|---|
| NCT07871877 | Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder | Not yet recruiting | Phase 1 | United States | Source start: 2027-07-01 (estimated)Source date detailsStart: 2027-07-01 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2029-01-31 (precision: day; source type: ESTIMATED; estimated) Study completion: 2029-12-31 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-13 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07888933 | Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay | Not yet recruiting | Phase 2 | Brazil | Source start: 2027-04-30 (estimated)Source date detailsStart: 2027-04-30 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2029-01-30 (precision: day; source type: ESTIMATED; estimated) Study completion: 2029-03-30 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-22 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07877987 | The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin | Not yet recruiting | Phase 1 | United States | Source start: 2027-03-01 (estimated)Source date detailsStart: 2027-03-01 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2030-06-30 (precision: day; source type: ESTIMATED; estimated) Study completion: 2030-06-30 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-16 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07774702 | Psilocybin for Methamphetamine Use Disorder | Not yet recruiting | Phase 2 | United States | Source start: 2027-02-01 (estimated)Source date detailsStart: 2027-02-01 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2032-02-01 (precision: day; source type: ESTIMATED; estimated) Study completion: 2032-02-01 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-21 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07566104 | Group PACBT for Depression | Not yet recruiting | Phase 2 | United States | Source start: 2027-01 (estimated) Saved start 2027-01-01 differs from reported 2027-01; the saved day is not established by this observation. Source date detailsStart: 2027-01 (precision: month; source type: ESTIMATED; estimated) Primary completion: 2028-12 (precision: month; source type: ESTIMATED; estimated) Study completion: 2028-12 (precision: month; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.566Z; registry revision: 2026-05-04 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07852832 | Effects of Psilocybin on Craving in Nicotine Dependence | Not yet recruiting | Phase 2 | Not reported | Source start: 2027-01 (estimated) Saved start 2027-01-01 differs from reported 2027-01; the saved day is not established by this observation. Source date detailsStart: 2027-01 (precision: month; source type: ESTIMATED; estimated) Primary completion: 2027-12 (precision: month; source type: ESTIMATED; estimated) Study completion: 2028-01 (precision: month; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-01 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07895134 | Psilocybin for Depression in Veterans | Not yet recruiting | Phase 2 | United States | Source start: 2027-01-01 (estimated)Source date detailsStart: 2027-01-01 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2031-12-31 (precision: day; source type: ESTIMATED; estimated) Study completion: 2031-12-31 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-26 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07719088 | Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life | Not yet recruiting | Phase 1 | United States | Source start: 2026-12 (estimated) Saved start 2026-12-01 differs from reported 2026-12; the saved day is not established by this observation. Source date detailsStart: 2026-12 (precision: month; source type: ESTIMATED; estimated) Primary completion: 2028-04 (precision: month; source type: ESTIMATED; estimated) Study completion: 2028-12 (precision: month; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-10-13 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07768618 | Electrophysiologic Mechanisms of Ketamine Antidepressant Response | Not yet recruiting | Phase 2 | United States | Source start: 2026-12 (estimated) Saved start 2026-12-01 differs from reported 2026-12; the saved day is not established by this observation. Source date detailsStart: 2026-12 (precision: month; source type: ESTIMATED; estimated) Primary completion: 2031-12 (precision: month; source type: ESTIMATED; estimated) Study completion: 2031-12 (precision: month; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-17 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07792538 | Psilocybin-Assisted Psychotherapy for Veterans With PTSD | Not yet recruiting | Phase 2 | Netherlands | Source start: 2026-12 (estimated) Saved start 2026-12-01 differs from reported 2026-12; the saved day is not established by this observation. Source date detailsStart: 2026-12 (precision: month; source type: ESTIMATED; estimated) Primary completion: 2028-12 (precision: month; source type: ESTIMATED; estimated) Study completion: 2028-12 (precision: month; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-28 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07818720 | MLS101 Study in PMDD | Not yet recruiting | Phase 1 | Not reported | Source start: 2026-12 (estimated) Saved start 2026-12-01 differs from reported 2026-12; the saved day is not established by this observation. Source date detailsStart: 2026-12 (precision: month; source type: ESTIMATED; estimated) Primary completion: 2027-09 (precision: month; source type: ESTIMATED; estimated) Study completion: 2027-12 (precision: month; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-14 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07833761 | ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder | Not yet recruiting | Phase 1 | United States | Source start: 2026-12-01 (estimated)Source date detailsStart: 2026-12-01 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2029-12-31 (precision: day; source type: ESTIMATED; estimated) Study completion: 2030-12-31 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-09-22 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07756736 | Psilocybin Therapy for Methamphetamine Use Disorder and HIV | Not yet recruiting | Phase 2 | United States | Source start: 2026-11 (estimated) Saved start 2026-11-01 differs from reported 2026-11; the saved day is not established by this observation. Source date detailsStart: 2026-11 (precision: month; source type: ESTIMATED; estimated) Primary completion: 2029-04 (precision: month; source type: ESTIMATED; estimated) Study completion: 2029-06 (precision: month; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-11 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07765693 | MDMA-AT for PTSD in Young Adults With Childhood Trauma | Not yet recruiting | Phase 2 | United States | Source start: 2026-10-31 (estimated)Source date detailsStart: 2026-10-31 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2028-01-30 (precision: day; source type: ESTIMATED; estimated) Study completion: 2028-12-01 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-20 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07791901 | MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial | Not yet recruiting | Phase 2 | Canada | Source start: 2026-10-30 (estimated)Source date detailsStart: 2026-10-30 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2027-12-20 (precision: day; source type: ESTIMATED; estimated) Study completion: 2027-12-31 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-02 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07683988 | Oral and Sublingual Ketamine | Not yet recruiting | Phase 1 | Not reported | Source start: 2026-10-01 (estimated)Source date detailsStart: 2026-10-01 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2027-08-01 (precision: day; source type: ESTIMATED; estimated) Study completion: 2027-10-01 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-06 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07704762 | Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder | Not yet recruiting | Phase 2 | Not reported | Source start: 2026-10-01 (estimated)Source date detailsStart: 2026-10-01 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2028-01-01 (precision: day; source type: ESTIMATED; estimated) Study completion: 2028-10-01 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-15 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07839338 | A Study Comparing Oral Ketamine With Oral Midazolam for the Treatment of Major Depressive Episodes | Not yet recruiting | Phase 3 | India | Source start: 2026-10 (estimated) Saved start 2026-10-01 differs from reported 2026-10; the saved day is not established by this observation. Source date detailsStart: 2026-10 (precision: month; source type: ESTIMATED; estimated) Primary completion: 2029-10 (precision: month; source type: ESTIMATED; estimated) Study completion: 2029-10 (precision: month; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-01 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07820033 | Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial | Not yet recruiting | Phase 2 | Canada | Source start: 2026-09-14 (estimated)Source date detailsStart: 2026-09-14 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2028-12-30 (precision: day; source type: ESTIMATED; estimated) Study completion: 2029-07-30 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-10-15 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07433452 | The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers. | Not yet recruiting | Phase 1 | Not reported | Source start: 2026-09-01 (estimated)Source date detailsStart: 2026-09-01 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2028-09-01 (precision: day; source type: ESTIMATED; estimated) Study completion: 2029-09-01 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-02-25 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07693257 | Neural Effects of Intravenous N,N-dimethyltryptamine (DMT) | Not yet recruiting | Phase 1 | United States | Source start: 2026-09-01 (estimated)Source date detailsStart: 2026-09-01 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2028-09-01 (precision: day; source type: ESTIMATED; estimated) Study completion: 2029-09-01 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-09 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07801703 | Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression | Not yet recruiting | Phase 2 | Canada | Source start: 2026-09 (estimated) Saved start 2026-09-01 differs from reported 2026-09; the saved day is not established by this observation. Source date detailsStart: 2026-09 (precision: month; source type: ESTIMATED; estimated) Primary completion: 2029-09 (precision: month; source type: ESTIMATED; estimated) Study completion: 2029-09 (precision: month; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-03 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07824973 | Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing | Not yet recruiting | Not applicable | Sweden | Source start: 2026-09 (estimated) Saved start 2026-09-01 differs from reported 2026-09; the saved day is not established by this observation. Source date detailsStart: 2026-09 (precision: month; source type: ESTIMATED; estimated) Primary completion: 2029-12 (precision: month; source type: ESTIMATED; estimated) Study completion: 2030-08 (precision: month; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-17 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07693153 | The Effects of Psilocybin on Social Connectedness | Not yet recruiting | Phase 1 | United States | Source start: 2026-08-31 (estimated)Source date detailsStart: 2026-08-31 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2031-12-15 (precision: day; source type: ESTIMATED; estimated) Study completion: 2031-12-15 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-09 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
| NCT07745569 | Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies | Not yet recruiting | Phase 2 | Not reported | Source start: 2026-12-31 (estimated) Saved start 2026-08-31 differs from reported 2026-12-31; the saved day is not established by this observation. Source date detailsStart: 2026-12-31 (precision: day; source type: ESTIMATED; estimated) Primary completion: 2030-06-30 (precision: day; source type: ESTIMATED; estimated) Study completion: 2030-06-30 (precision: day; source type: ESTIMATED; estimated) Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-10-30 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred. |
Other substance hubs
Psilocybin | MDMA | LSD | DMT | 5-MeO-DMT | Ayahuasca | Ketamine | Ibogaine
Registry status hubs
Recruiting | Active, not recruiting | Enrolling by invitation | Completed | Terminated | Suspended | Withdrawn
Phase hubs
Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Phase not applicable